Equity · Healthcare
OMER
Omeros Corporation · NasdaqGM
The line runs $14.77 on 12 May through $9.68 on 17 July, on a scale from $8 to $16. Days the market did not trade hold the previous close, flat.
The chart above plots the price of OMER over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 46 sessions over that window: $14.77 on 12 May 2026 through $9.68 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 10, 2026
OMER insider trades
OMER has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 13 October 2025.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
OMER reported financials
OMER reported net income of −$3.4M for the fiscal year ended 31 Dec 2025.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
OMER earnings
Reported figures & scheduled dates · SEC EDGAR filings
OMER institutional holders
7 of the 45 institutional funds we track reported a OMER position for the quarter ended 31 Mar 2026 — a combined $12.4M; the latest of those filings landed 15 May 2026.
Source: SEC EDGAR 13F filings
OMER fails-to-deliver
On 14 Jul 2026, 4,936 shares of OMER failed to deliver (about $49K) — the latest of at least 12 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier.
Source: SEC fails-to-deliver (CNS) data